Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.69NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.69NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.70NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.70NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.72NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.72NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.73NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.73NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDZNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDZNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XEBNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XEBNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.302NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.302NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.222NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.222NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.434NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.434NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.467NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.467NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.110.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.110.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.23 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.263NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.263NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.180NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.180NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.464NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.464NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.234NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.234NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.231NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.231NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.243NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.517NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.517NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.291NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.291NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.349NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.349NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.314NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.314NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used